This demonstration aims to evaluate the effectiveness of metformin in managing glycemic control among individuals diagnosed with type 2 diabetes, as measured by hemoglobin A1c levels. Using data from the All of Us Research Program, we will study A1c levels in a cohort of patients who have been prescribed metformin, excluding those who were pregnant during the study period. The goal in this research could be to identify patterns in A1c outcomes and assess the impact of metformin therapy on long-term glycemic control in a diverse population.
Workspace name:
Data access tier: Registered Tier (The Registered Tier includes data from electronic health records (EHRs), wearables, surveys, and physical measurements) OR Controlled Tier (In addition to the data in the Registered Tier, the Controlled Tier dataset contains genomic data in the form of short-read whole genome sequences (WGS), long-read WGS, structural variants, and genotyping arrays; previously suppressed demographic data fields from EHRs and surveys; and unshifted dates of events). USD has access to Controlled Tier.
Dataset version: Select which version of Curated Data Repository you wish to query in this workspace—recommended - Most recent version.
Research Use Statement Questions
Include: type 2 diabetes (condition) AND metformin (drug) AND a1c (labs & measurements)
Exclude: pregnant (condition)
Combine the Cohort AND Concept Sets
Select your preferred programming language to use from Python, R, and SAS.